Normal and aberrant biological self-assembly: Insights from studies of human lyspzyme and its amyloidogenic variants

Accounts of Chemical Research

Volumn 39, Issue 9, 2006, Pages 603-610

  Dumoulin, Mireille ^a   Kumita, Janet R ^a   Dobson, Christopher M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; LYSOZYME;

CHEMISTRY; HUMAN; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; REVIEW;

AMYLOID; HUMANS; MURAMIDASE; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING;

EID: 33749831531     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar050070g     Document Type: Review

References (37)

1. Pepys, M. B.; Hawkins, P. N.; Booth, D. R.; Vigushin, D. M.; Tennent, G. A.; Soutar, A. K.; Totty, N.; Nguyen, O.; Blake, C. C. F.; Terry, C. J.; Feest, T. G.; Zalin, A. M.; Hsuan, J. J. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993, 362, 553-557.
2. Valleix, S.; Drunat, S.; Philit, J. B.; Adoue, D.; Piette, J. C.; Droz, D.; MacGregor, B.; Canet, D.; Delpech, M.; Grateau, G. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int. 2002, 61, 907-912.
3. Yazaki, M.; Farrell, S. A.; Benson, M. D. A novel lysozyme mutation Phe57lle associated with hereditary renal amyloidosis. Kidney Int. 2003, 63, 1652-1657.
4. Rocken, C.; Becker, K.; Fandrich, M.; Schroeckh, V.; Stix, B.; Rath, T.; Kahne, T.; Dierkes, J.; Roessner, A.; Albert, F. W. ALys amyloidosis caused by compound heterozygosity in Exon 2 (Thr70Asn) and Exon 4 (Trp112Arg) of the lysozyme gene. Hum. Mutat. 2005, 27, 119-120.
5. Booth, D. R.; Pepys, M. B.; Hawkins, P. N. A novel variant of human lysozyme (T70N) is common in the normal population. Hum. Mutat. 2000, 16, 180.
6. Dumoulin, M.; Bellotti, V.; Dobson, C. M. Hereditary systemic amyloidosis associated with mutational variants of human lysozyme. In The beta pleated sheet conformation and disease; Sipe, J. D., Ed.; VCH Verlag GmbH & Co KgaA publisher: Weinheim, Germany, 2005; pp 635-656.
7. Dumoulin, M.; Johnson, R. J. K.; Belotti, V.; Dobson, C. M. Human lysozyme. In Protein misfolding, aggregation and conformational diseases. II. Molecular basis of conformational diseases; Fink, A. L., Ed.; Kluwer Academic: Dordrecht, The Netherlands, 2006; Vol. II; in press.
8. Booth, D. R.; Sunde, M.; Bellotti, V.; Robinson, C. V.; Hutchinson, W. L.; Fraser, P. E.; Hawkins, P. N.; Dobson, C. M.; Radford, S. E.; Blake, C. C. F.; Pepys, M. B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997, 385, 787-793.
9. Johnson, J. R. K.; Christodoulou, J.; Dumoulin, M.; Caddy, G.; Alcocer, M. J.; Murtagh, G. J.; Kumita, J. R.; Larsson, G.; Robinson, C. V.; Archer, D. B.; Luisi, B.; Dobson, C. M. Rationalising lysozyme amyloidosis: Insight from the structure and solution dynamics of T70N lysozyme. J. Mol. Biol. 2005, 352, 823-836.
10. Esposito, G.; Garcia, J.; Mangione, P.; Giorgetti, S.; Corazza, A.; Viglino, P.; Chili, F.; Andreola, A.; Dumy, P.; Booth, D.; Hawkins, P. N.; Bellotti, V. Structural and folding dynamics properties of T70N variant of human lysozyme. J. Biol. Chem. 2003, 278, 25910-25918.
11. Wain, R.; Smith, L. J.; Dobson, C. M. Oxidative refolding of amyloidogenic variants of human lysozyme. J. Mol. Biol. 2005, 351, 662-671.
12. Canet, D.; Sunde, M.; Last, A. M.; Miranker, A.; Spencer, A.; Robinson, C. V.; Dobson, C. M. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants. Biochemistry 1999, 38, 6419-6427.
13. Hooke, S. D.; Radford, S. E.; Dobson, C. M. The refolding of human lysozyme: a comparison with the structurally homologous hen lysozyme. Biochemistry 1994, 33, 5867-5876.
14. Dobson, C. M.; Evans, P. A.; Radford, S. E. Understanding how proteins fold: the lysozyme story so far. Trends Biochem. Sci. 1994, 19, 31-37.
15. Dinner, A. R.; Sali, A.; Smith, L. J.; Dobson, C. M.; Karplus, M. Understanding protein folding via free-energy surfaces from theory and experiment. Trends Biochem. Sci. 2000, 25, 331-339.
16. Dumoulin, M.; Canet, D.; Last, A. M.; Pardon, E.; Archer, D. B.; Muyldermans, S.; Wyns, L.; Matagne, A.; Robinson, C. V.; Redfield, C.; Dobson, C. M. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. J. Mol. Biol. 2005, 346, 773-788.
17. Kumita, J. R.; Johnson, J. R. K.; Alcocer, M. J.; Dumoulin, M.; Holinquist, F.; McCammon, M. G.; Robinson, C. V.; Archer, D. B.; Dobson, C. M. Expression of the amyloidogenic human lysozyme variants F57I and W64R in Pichia pastoris: Impact of native state stability on protein secretion levels. FEBS J. 2006, 273, 711-720.
18. Morozova-Roche, L. A.; Zurdo, J.; Spencer, A.; Noppe, W.; Receveur, V.; Archer, D. B.; Joniau, M.; Dobson, C. M. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 2000, 130 339-351.
19. Canet, D.; Last, A. M.; Tito, P.; Sunde, M.; Spencer, A.; Archer, D. B.; Redfield, C.; Robinson, C. V.; Dobson, C. M. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat. Struct. Biol. 2002, 9, 308-315.
20. Frare, E.; Polverino de Laureto, P.; Zurdo, J.; Dobson, C. M.; Fontana, A. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 2004, 340, 1153-1165.
21. Pawar, A. P.; Dubay, K. F.; Zurdo, J.; Chiti, F.; Vendruscolo, M.; Dobson, C. M. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 2005, 350, 379-392.
22. Dumoulin, M.; Conrath, K.; Van Meirhaeghe, A.; Meersman, F.; Heremans, K.; Frenken, L. G.; Muyldermans, S.; Wyns, L.; Matagne, A. Single-domain antibody fragments with high conformational stability. Protein Sci. 2002, 11, 500-515.
23. Dumoulin, M.; Last, A. M.; Desmyter, A.; Decanniere, K.; Canet, D.; Larsson, G.; Spencer, A.; Archer, D. B.; Sasse, J.; Muyldermans, S.; Wyns, L.; Redfield, C.; Matagne, A.; Robinson, C. V.; Dobson, C. M. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 2003, 424, 783-788.
24. Dobson, C. M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24, 329-332.
25. Guijarro, J. I.; Sunde, M.; Jones, J. A.; Campbell, I. D.; Dobson, C. M. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4224-4228.
26. Litvinovich, S. V.; Brew, S. A.; Aota, S.; Akiyama, S. K.; Haudenschild, C.; Ingham, K. C. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J. Mol. Biol. 1998, 280, 245-258.
27. Stefani, M.; Dobson, C. M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 2003, 81, 678-699.
28. Dobson, C. M. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 2004, 15, 3-16.
29. Branden, C.; Tooze, J. Introduction to protein structure, 2nd ed.; Garland Publishing: New York, 1999.
30. Jaroniec, C. P.; MacPhee, C. E.; Bajaj, V. S.; McMahon, M. T.; Dobson, C. M.; Griffin, R. G. High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 711-716.
31. Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Madsen, A. O.; Riekel, C.; Grothe, R.; Eisenberg, D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005, 435, 773-778.
32. Krebs, M. R.; Morozova-Roche, L. A.; Daniel, K.; Robinson, C. V.; Dobson, C. M. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci. 2004, 13, 1933-1938.
33. Fandrich, M.; Dobson, C. M. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 2002, 21, 5682-5690.
34. Dobson, C. M. Getting out of shape. Nature 2002, 418, 729-730.
35. Gillmore, J. D.; Booth, D. R.; Madhoo, S.; Pepys, M. B.; Hawkins, P. N. Hereditary renal amyloidosis associated with variant lysozyme in a large English family. Nephrol., Dial., Transplant. 1999, 14, 2639-2644.
36. Vendruscolo, M.; Paci, E.; Karplus, M.; Dobson, C. M. Structures and relative free energies of partially folded states of proteins. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 14817-14821.
37. Dumoulin, M.; Dobson, C. M. Probing the origins, diagnosis and treatment of amyloid diseases using antibodies. Biochimie 2004, 86, 589-600.